Synapse - Eileen O'Reilly

Results (790)

Alliance A021501: Preoperative mFOLFIRINOX or mFOLFIRINOX plus hypofractionated radiation therapy (RT) for borderline resectable (BR) adenocarcinoma of the pancreas

Meeting Abstract

Katz, M. H. G.; Shi, Q.; Meyers, J. P.; Herman, J. M.; Choung, M.; Wolpin, B. M.; Ahmad, S.; de Wilton Marsh, R.; Schwartz, L. H.; Behr, S.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Discordance between central versus local response assessments in neuroendocrine tumor (NET) patients (pts) enrolled in A021202

Meeting Abstract

Geyer, S. M.; Mahoney, M. R.; Asmis, T. R.; Hall, N.; Karovic, S.; Knopp, M. V.; Kumthekar, P.; Nixon, A. B.; O'Reilly, E. M.; Schwartz, L. H.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Overall survival from the phase 3 POLO trial: Maintenance olaparib for germline BRCA-mutated metastatic pancreatic cancer

Meeting Abstract

Golan, T.; Hammel, P.; Reni, M.; Van Cutsem, E.; Macarulla, T.; Hall, M. J.; Park, J. O.; Hochhauser, D.; Arnold, D.; Oh, D. Y.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Radiomic signatures to predict survival in patients with advanced hepatocellular carcinoma (HCC) treated with sorafenib +/- doxorubicin: Correlative science from CALGB 80802 (Alliance)

Meeting Abstract

Dercle, L.; Geyer, S. M.; Nixon, A. B.; Innocenti, F.; Shi, Q.; Jacobson, S. B.; Luk, L.; Liu, A.; Yang, H.; Wen, Y.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Alliance/CALGB 80802: Impact of hepatitis C (HCV) on doxorubicin (DO) + sorafenib (S) versus S in patients (pts) with advanced hepatocellular carcinoma (aHCC)

Meeting Abstract

El Dika, I. H.; Geyer, S. M.; Nixon, A. B.; Innocenti, F.; Shi, Q.; Jacobson, S. B.; Yaqubie, A.; Lopez, J. C.; Huang, B. H.; Tang, Y. W.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Randomized phase II trial of olaparib + pembrolizumab versus olaparib alone as maintenance therapy in metastatic pancreatic cancer patients with germline BRCA1 or BRCA2 (gBRCA1/2+) mutations: SWOG S2001

Meeting Abstract

Chung, V.; Guthrie, K. A.; Pishvaian, M. J.; Lowy, A. M.; Chiorean, E. G.; Duong, M. T.; O'Reilly, E. M.; Philip, P. A.
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Prognostic value of tumor deposits in stage III colon cancer patients, a post-hoc analysis of CALGB/SWOG 80702 phase III study

Meeting Abstract

Cohen, R.; Shi, Q.; Meyers, J. P.; Jin, Z.; Svrcek, M.; Fuchs, C. S.; Couture, F.; Kuebler, J. P.; Bendell, J. C.; De Jesus-Acosta, A.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Evaluation of neratinib (N), pembrolizumab (P), everolimus (E), and nivolumab (V) in patients (pts) with fibrolamellar carcinoma (FLC)

Meeting Abstract

Abou-Alfa, G. K.; Meyer, T.; Zhang, J.; Sherrin, S.; Yaqubie, A.; O'Neill, A. C.; Xu, F.; Eli, L. D.; Harding, J. J.; O'Reilly, E. M.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Treatment of pancreatic cancer by intra-arterial injection of an emulsion of lipiodol and bumetanide (an anti-glycolytic drug) in a transgenic mutated pig model (Oncopig)

Meeting Abstract

Yarmohammadi, H.; Elsakka, A.; Nurili, F.; Maxwell, A.; Ridouani, F.; Ziv, E.; O'Reilly, E.; Cheleuitte-Nieves, C.; Schook, L.; Solomon, S.; more...
Journal of Vascular and Interventional Radiology (2021)

Fulltext@MSK | Save

Noninvasive detection of polyclonal acquired resistance to FGFR inhibition in patients with cholangiocarcinoma harboring FGFR2 alterations

Journal Article

Varghese, A. M.; Patel, J.; Janjigian, Y. Y.; Meng, F.; Selcuklu, S. D.; Iyer, G.; Houck-Loomis, B.; Harding, J. J.; O'Reilly, E. M.; Abou-Alfa, G. K.; more...
JCO Precision Oncology (2021)

Fulltext@MSK | Save